Experts: Regular Supplier Audits, Quality Agreements Are Key

Drug GMP Report
Manufacturers should conduct audits every 12 to 18 months for suppliers of critical materials, such as active pharmaceutical ingredients, perform a risk analysis to identify areas of concern for monitoring, and always should negotiate quality agreements before signing a contract with a new supplier, experts say.

To View This Article:


Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $20.00